|
FI3240805T3
(fi)
|
2014-12-15 |
2025-02-17 |
Univ California |
Cd19- ja cd20-vasteellinen bispesifinen tai-veräjän kimeerinen antigeenireseptori
|
|
EP3234120B1
(en)
|
2014-12-15 |
2025-09-03 |
The Regents of the University of California |
Cytotoxic molecules responsive to intracellular ligands for selective t cell mediated killing
|
|
KR102763121B1
(ko)
|
2015-02-06 |
2025-02-04 |
내셔널 유니버시티 오브 싱가포르 |
치료적 면역 세포의 효능의 향상 방법
|
|
US20220241327A1
(en)
*
|
2015-06-25 |
2022-08-04 |
Icell Gene Therapeutics Llc |
Chimeric Antigen Receptor (CAR) Targeting Multiple Antigens, Compositions and Methods of Use Thereof
|
|
US20220348633A1
(en)
*
|
2015-06-25 |
2022-11-03 |
Icell Gene Therapeutics Llc |
COMPOUND CHIMERIC ANTIGEN RECEPTOR (cCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHOD OF USE THEREOF
|
|
US11655452B2
(en)
*
|
2015-06-25 |
2023-05-23 |
Icell Gene Therapeutics Inc. |
Chimeric antigen receptors (CARs), compositions and methods of use thereof
|
|
PL3368571T3
(pl)
|
2015-10-30 |
2023-05-02 |
The Regents Of The University Of California |
Polipeptydy odpowiadające na transformujący czynnik wzrostu beta i sposoby ich zastosowania
|
|
CN108472365A
(zh)
|
2015-10-30 |
2018-08-31 |
艾丽塔生物治疗剂公司 |
用于肿瘤转导的组合物和方法
|
|
US10508143B1
(en)
|
2015-10-30 |
2019-12-17 |
Aleta Biotherapeutics Inc. |
Compositions and methods for treatment of cancer
|
|
US11384156B2
(en)
*
|
2016-07-25 |
2022-07-12 |
The Nemours Foundation |
Adoptive T-cell therapy using EMPD-specific chimeric antigen receptors for treating IgE-mediated allergic diseases
|
|
KR102546839B1
(ko)
|
2016-08-03 |
2023-06-23 |
워싱턴 유니버시티 |
키메라 항원 수용체를 이용한 t 세포 악성종양의 치료를 위한 car-t 세포의 유전자 편집
|
|
AU2017319702B2
(en)
|
2016-09-02 |
2024-11-14 |
The Regents Of The University Of California |
Methods and compositions involving interleukin-6 receptor alpha-binding single chain variable fragments
|
|
JP2019535262A
(ja)
*
|
2016-11-11 |
2019-12-12 |
オートラス リミテッド |
キメラ抗原受容体
|
|
EP3567049A4
(en)
|
2016-12-28 |
2020-08-26 |
Green Cross Lab Cell Corporation |
CHEMERICAL ANTIGENIC RECEPTOR AND NATURAL KILLER CELLS EXPRESSING THE SAME
|
|
CA3048648A1
(en)
*
|
2017-01-10 |
2018-07-19 |
The General Hospital Corporation |
T cells expressing a chimeric antigen receptor
|
|
EP3568466A4
(en)
|
2017-01-10 |
2020-07-15 |
The General Hospital Corporation |
TARGETED T CELLS WITH CYTOTOXICITY TO IMMUNOSUPPRESSIVE CELLS
|
|
RU2019130504A
(ru)
|
2017-02-28 |
2021-03-30 |
Вор Байофарма, Инк. |
Композиции и способы ингибирования линиеспецифических белков
|
|
WO2018191619A1
(en)
|
2017-04-13 |
2018-10-18 |
Senti Biosciences, Inc. |
Combinatorial cancer immunotherapy
|
|
US12378297B2
(en)
|
2017-04-14 |
2025-08-05 |
The General Hospital Corporation |
Chimeric antigen receptor T cells targeting the tumor microenvironment
|
|
EP3612210A4
(en)
*
|
2017-04-19 |
2021-01-27 |
Board Of Regents, The University Of Texas System |
MANIPULATED ANTIGEN RECEPTORS EXPRESSING IMMUNE CELLS
|
|
MX2019013514A
(es)
|
2017-05-12 |
2020-01-20 |
Crispr Therapeutics Ag |
Materiales y metodos para modificar celulas por ingenieria genetica y usos de los mismos en inmunooncologia.
|
|
US11166985B2
(en)
|
2017-05-12 |
2021-11-09 |
Crispr Therapeutics Ag |
Materials and methods for engineering cells and uses thereof in immuno-oncology
|
|
CA3287539A1
(en)
|
2017-06-21 |
2026-03-02 |
Icell Gene Therapeutics Llc |
CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOF
|
|
JP2020530280A
(ja)
|
2017-07-03 |
2020-10-22 |
トルク セラピューティクス， インコーポレイテッド |
免疫刺激性融合分子およびその使用
|
|
WO2019028051A1
(en)
*
|
2017-07-31 |
2019-02-07 |
Lentigen Technology, Inc. |
COMPOSITIONS AND METHODS FOR TREATING CANCER BY ANTI-CD19 / CD20 IMMUNOTHERAPY
|
|
US20190038733A1
(en)
|
2017-08-10 |
2019-02-07 |
National University Of Singapore |
T cell receptor-deficient chimeric antigen receptor t-cells and methods of use thereof
|
|
JP7749319B2
(ja)
|
2017-10-10 |
2025-10-06 |
アルパイン イミューン サイエンシズ インコーポレイテッド |
Ｃｔｌａ－４変異型免疫調節タンパク質およびそれらの使用
|
|
CN117721084A
(zh)
*
|
2017-10-12 |
2024-03-19 |
美商生物细胞基因治疗有限公司 |
靶向多种抗原的复合嵌合抗原受体（cCAR）及其组成和使用方法
|
|
WO2019084273A1
(en)
|
2017-10-25 |
2019-05-02 |
Actinium Pharmaceuticals, Inc. |
METHODS OF ANTI-CD45-BASED LYMPHODEPPLICATION AND USES THEREOF IN COMBINATION WITH ACT-BASED ANTICANCER THERAPIES
|
|
PT3703750T
(pt)
|
2017-11-01 |
2025-01-17 |
Memorial Sloan Kettering Cancer Center |
Recetores de antigénio quimérico específicos para o antigénio de maturação das células b e polinucleótidos codificantes
|
|
SG11202003501XA
(en)
|
2017-11-01 |
2020-05-28 |
Juno Therapeutics Inc |
Antibodies and chimeric antigen receptors specific for b-cell maturation antigen
|
|
KR102774451B1
(ko)
|
2017-11-14 |
2025-02-28 |
앱클론(주) |
항-her2 항체 또는 그의 항원 결합 단편, 및 이를 포함하는 키메라 항원 수용체
|
|
US11649294B2
(en)
|
2017-11-14 |
2023-05-16 |
GC Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
KR20190065234A
(ko)
*
|
2017-11-30 |
2019-06-11 |
그리폴스 다이어그노스틱 솔루션즈 인크. |
면역 관문 억제제인 pd-1 및 pd-l1에 대한 항체 치료를 모니터링하기 위한 면역분석 및 조작된 단백질
|
|
JP7566628B2
(ja)
*
|
2018-01-10 |
2024-10-15 |
ザ ジェネラル ホスピタル コーポレイション |
キメラ抗原受容体を発現する免疫細胞
|
|
CN108314738B
(zh)
*
|
2018-01-29 |
2020-09-08 |
山东兴瑞生物科技有限公司 |
一种共表达细胞因子il-21的双特异性嵌合抗原受体、质粒、cik细胞及mm病应用
|
|
EP3749685A4
(en)
|
2018-02-09 |
2021-12-22 |
National University of Singapore |
ACTIVATOR CHEMERIC RECEPTORS AND THEIR USES IN NATURAL KILLING CELL IMMUNOTHERAPY
|
|
US20200399383A1
(en)
*
|
2018-02-13 |
2020-12-24 |
Novartis Ag |
Chimeric antigen receptor therapy in combination with il-15r and il15
|
|
CN112041432A
(zh)
*
|
2018-02-15 |
2020-12-04 |
纪念斯隆-凯特林癌症中心 |
Foxp3靶向剂组合物以及用于过继细胞疗法的使用方法
|
|
US12473336B2
(en)
|
2018-02-21 |
2025-11-18 |
Board Of Regents, The University Of Texas System |
Methods for activation and expansion of natural killer cells and uses thereof
|
|
CN112955184A
(zh)
*
|
2018-03-15 |
2021-06-11 |
基本解决方案公司 |
可编程免疫细胞受体复合物系统
|
|
US11168138B2
(en)
|
2018-03-26 |
2021-11-09 |
Altor Bioscience, Llc |
Anti-PDL1, IL-15 and TGF-beta receptor combination molecules
|
|
JP7334985B2
(ja)
|
2018-04-02 |
2023-08-29 |
ナショナル ユニヴァーシティー オブ シンガポール |
免疫細胞で発現される膜結合抗サイトカイン非シグナル伝達バインダーによるヒトサイトカインの中和
|
|
CN111954527A
(zh)
*
|
2018-04-09 |
2020-11-17 |
梅约医学教育与研究基金会 |
治疗移植物抗宿主病的方法和材料
|
|
TW202322828A
(zh)
*
|
2018-04-12 |
2023-06-16 |
美商凱特製藥公司 |
利用腫瘤微環境之特性之嵌合受體ｔ細胞治療
|
|
EP3561053A1
(en)
*
|
2018-04-26 |
2019-10-30 |
Baylor College of Medicine |
Immune effector cells and molecular adaptors with an antigen cytokine complex for effective cancer immunotherapy
|
|
EP3784256A4
(en)
*
|
2018-04-27 |
2022-06-29 |
Baylor College of Medicine |
Car t cells with one or more interleukins
|
|
US12473342B2
(en)
|
2018-04-27 |
2025-11-18 |
The Trustees Of The University Of Pennsylvania |
Chimeric antigen receptor T regulatory cells for the treatment of atherosclerosis
|
|
CN110468105B
(zh)
*
|
2018-05-09 |
2024-03-22 |
恺兴生命科技(上海)有限公司 |
表达il-18r结合蛋白的免疫效应细胞
|
|
MX2020012028A
(es)
|
2018-05-11 |
2021-03-29 |
Crispr Therapeutics Ag |
Metodos y composiciones para tratar el cancer.
|
|
CN112566643A
(zh)
*
|
2018-06-12 |
2021-03-26 |
加利福尼亚大学董事会 |
用于治疗癌症的单链双特异性嵌合抗原受体
|
|
DK3806903T5
(da)
|
2018-06-14 |
2024-08-19 |
2Seventy Bio Inc |
Cd79a kimæriske antigenreceptorer
|
|
WO2019246593A2
(en)
*
|
2018-06-22 |
2019-12-26 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to target cll-1 and cd123 for the treatment of acute myeloid leukemia and related disorders
|
|
WO2020009868A1
(en)
|
2018-07-03 |
2020-01-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-slamf7 chimeric antigen receptors
|
|
CN108864307A
(zh)
*
|
2018-07-23 |
2018-11-23 |
北京多赢时代科技有限公司 |
信号肽优化靶向cd19的嵌合抗原受体、表达该嵌合抗原受体的t细胞及制备方法和应用
|
|
US20210079111A1
(en)
*
|
2018-08-04 |
2021-03-18 |
AbCyte Therapeutics Inc. |
Cd19-cd20 bispecific and dual passway car-t and methods for use thereof
|
|
CN110862967A
(zh)
*
|
2018-08-27 |
2020-03-06 |
天津天锐生物科技有限公司 |
一种不依赖细胞因子培养的自然杀伤细胞系silk-nk
|
|
CA3110837A1
(en)
|
2018-08-28 |
2020-03-05 |
Vor Biopharma Inc. |
Genetically engineered hematopoietic stem cells and uses thereof
|
|
CN112771166B
(zh)
*
|
2018-08-31 |
2025-03-04 |
诺伊尔免疫生物科技株式会社 |
表达car的t细胞和car表达载体
|
|
AU2019335014A1
(en)
*
|
2018-09-05 |
2021-03-25 |
Poseida Therapeutics, Inc. |
Allogeneic cell compositions and methods of use
|
|
WO2020061796A1
(en)
*
|
2018-09-26 |
2020-04-02 |
Hrain Biotechnology Co., Ltd. |
Bcma-and-cd19-targeting chimeric antigen receptor and uses thereof
|
|
CN110950965B
(zh)
*
|
2018-09-26 |
2021-10-15 |
重庆精准生物技术有限公司 |
抗人cd123的嵌合抗原受体及其应用
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
US20210338729A1
(en)
*
|
2018-10-12 |
2021-11-04 |
Icell Gene Therapeutics Llc |
CHIMERIC ANTIGEN RECEPTORS (CARs) COMPOSITIONS AND METHODS OF USE THEREOF
|
|
AU2019359890B2
(en)
*
|
2018-10-17 |
2024-10-24 |
Senti Biosciences, Inc. |
Combinatorial cancer immunotherapy
|
|
US11419898B2
(en)
|
2018-10-17 |
2022-08-23 |
Senti Biosciences, Inc. |
Combinatorial cancer immunotherapy
|
|
EP3873540A4
(en)
|
2018-10-31 |
2022-07-27 |
Mayo Foundation for Medical Education and Research |
METHODS AND MATERIALS FOR THE TREATMENT OF CANCER
|
|
WO2020092839A1
(en)
|
2018-10-31 |
2020-05-07 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
AU2019372673A1
(en)
|
2018-11-01 |
2021-05-27 |
Gracell Biotechnologies (Shanghai) Co., Ltd. |
Compositions and methods for T cell engineering
|
|
MA54078A
(fr)
|
2018-11-01 |
2021-09-15 |
Juno Therapeutics Inc |
Méthodes pour le traitement au moyen de récepteurs antigéniques chimériques spécifiques de l'antigene de maturation des lymphocytes b
|
|
EP3873937A2
(en)
*
|
2018-11-01 |
2021-09-08 |
Juno Therapeutics, Inc. |
Chimeric antigen receptors specific for g protein-coupled receptor class c group 5 member d (gprc5d)
|
|
CA3120563A1
(en)
|
2018-11-26 |
2020-06-04 |
Nkarta, Inc. |
Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
|
|
WO2020113054A1
(en)
|
2018-11-30 |
2020-06-04 |
Mustang Bio, Inc. |
Methods of treatment using decitabine and a cd123-targeted therapy
|
|
AU2019397033B2
(en)
*
|
2018-12-12 |
2023-06-29 |
Kite Pharma, Inc. |
Chimeric antigen receptors and CAR-T cells and methods of use
|
|
WO2020124021A1
(en)
*
|
2018-12-13 |
2020-06-18 |
The General Hospital Corporation |
Chimeric antigen receptors targeting cd79b and cd19
|
|
CA3124721A1
(en)
*
|
2018-12-24 |
2020-07-02 |
Xiaoyi Zhou |
Recombinant human 21g-b7-h3 protein coding gene, recombinant vector, host cell comprising the same, pharmaceutical composition and use thereof
|
|
EP3908613A4
(en)
*
|
2019-01-07 |
2022-10-19 |
Celluris Participações Ltda. |
BISPECIFIC IN-TANDEM RECEPTOR CAR AND METHODS FOR MODULATION OF THE TUMOR MICROAREA
|
|
WO2020159656A1
(en)
*
|
2019-02-01 |
2020-08-06 |
Actinium Pharmaceuticals, Inc. |
Molecules and their derivatives directed against cd45
|
|
EP3773918A4
(en)
|
2019-03-05 |
2022-01-05 |
Nkarta, Inc. |
CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY
|
|
KR102298639B1
(ko)
|
2019-03-28 |
2021-09-07 |
한국생명공학연구원 |
면역세포의 제조방법 및 그의 용도
|
|
WO2020210719A1
(en)
*
|
2019-04-10 |
2020-10-15 |
Elevatebio Management, Inc. |
Flt3-specific chimeric antigen receptors and methods of using the same
|
|
CN110055281B
(zh)
*
|
2019-04-25 |
2020-09-01 |
山东大学第二医院 |
一种用于制备car-t的慢病毒载体及其构建方法和应用
|
|
TW202110873A
(zh)
*
|
2019-04-30 |
2021-03-16 |
美商聖堤生物科技股份有限公司 |
嵌合受體及其使用方法
|
|
MX2021013359A
(es)
|
2019-04-30 |
2022-01-31 |
Crispr Therapeutics Ag |
Terapia de celulas alogénicas de neoplasias malignas de células b usando células t modificadas genéticamente dirigidas a cd19.
|
|
WO2020223535A1
(en)
*
|
2019-05-01 |
2020-11-05 |
Juno Therapeutics, Inc. |
Cells expressing a recombinant receptor from a modified tgfbr2 locus, related polynucleotides and methods
|
|
EP3747904A1
(en)
*
|
2019-06-03 |
2020-12-09 |
Universität Regensburg |
Cd25-specific chimeric antigen receptors and their uses
|
|
EP3980453A4
(en)
*
|
2019-06-07 |
2023-07-05 |
The Trustees of the University of Pennsylvania |
Dual car expressing t cells individually linked to cd28 and 4-1bb
|
|
WO2020252110A1
(en)
*
|
2019-06-14 |
2020-12-17 |
Bluebird Bio, Inc. |
Compositions and methods for treating cancer
|
|
US20230181027A1
(en)
*
|
2019-06-28 |
2023-06-15 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating neuromyelitis optica spectrum diseases
|
|
CN112204135B
(zh)
*
|
2019-07-06 |
2026-03-06 |
苏州克睿基因生物科技有限公司 |
一种表达cd3抗体受体复合物的免疫细胞及其用途
|
|
WO2021007580A1
(en)
*
|
2019-07-11 |
2021-01-14 |
Valkyr, Inc. |
System and methods relating to chimeric autoantibody receptors
|
|
AU2020315213A1
(en)
*
|
2019-07-17 |
2022-02-03 |
National University Of Singapore |
Functional binders synthesized and secreted by immune cells
|
|
CN110452294B
(zh)
*
|
2019-08-06 |
2020-08-07 |
复旦大学 |
五种铰链区及其嵌合抗原受体和免疫细胞
|
|
WO2021041936A1
(en)
*
|
2019-08-28 |
2021-03-04 |
Montefiore Medical Center |
Cd25 chimeric antigen receptors and uses thereof
|
|
WO2021057906A1
(zh)
*
|
2019-09-25 |
2021-04-01 |
科济生物医药（上海）有限公司 |
表达il-15的免疫效应细胞
|
|
EP4041294A4
(en)
*
|
2019-10-01 |
2024-10-02 |
Case Western Reserve University |
TARGETING B-CELL ACTIVATING FACTOR RECEPTOR (BAFF-R) USING LIGAND-BASED CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS
|
|
CA3153441A1
(en)
*
|
2019-10-01 |
2021-04-08 |
Reshmi Parameswaran |
Targeting b cell activating factor receptor (baff-r) using ligand-based chimeric antigen receptor (car)-t cells
|
|
EP4041297A4
(en)
*
|
2019-10-11 |
2024-02-28 |
The Trustees of The University of Pennsylvania |
COMPOSITIONS AND METHODS FOR TARGETING CD13 AND TIM-3 WITH CAR-T CELLS FOR TREATING ACUTE MYELOID LEUKEMIA
|
|
TWI717880B
(zh)
|
2019-10-24 |
2021-02-01 |
中國醫藥大學附設醫院 |
Hla-g特異性嵌合抗原受體、核酸、hla-g特異性嵌合抗原受體表達質體、表達hla-g特異性嵌合抗原受體細胞、其用途以及用於治療癌症之醫藥組合物
|
|
CN115925976A
(zh)
*
|
2019-11-21 |
2023-04-07 |
博生吉医药科技(苏州)有限公司 |
Cd7-car-t细胞及其制备和应用
|
|
JP2023504884A
(ja)
*
|
2019-12-05 |
2023-02-07 |
ヴィセリックス・インコーポレーティッド |
ユニバーサル細胞療法のための免疫逃避機構のモジュレーター
|
|
EP4069742A1
(en)
|
2019-12-06 |
2022-10-12 |
Juno Therapeutics, Inc. |
Anti-idiotypic antibodies to gprc5d-targeted binding domains and related compositions and methods
|
|
CN115397460A
(zh)
*
|
2020-02-27 |
2022-11-25 |
诺华股份有限公司 |
制备表达嵌合抗原受体的细胞的方法
|
|
US20230174653A1
(en)
*
|
2020-04-06 |
2023-06-08 |
St. Jude Children's Research Hospital, Inc. |
B7-h3 chimeric antigen receptors
|
|
CN111411085A
(zh)
*
|
2020-04-10 |
2020-07-14 |
格源致善(上海)生物科技有限公司 |
一种嵌合抗原受体t细胞及其应用
|
|
CN113527507A
(zh)
*
|
2020-04-16 |
2021-10-22 |
上海赛比曼生物科技有限公司 |
靶向cd22的嵌合抗原受体及其制法和应用
|
|
WO2021223705A1
(en)
*
|
2020-05-06 |
2021-11-11 |
Gracell Biotechnologies (Shanghai) Co., Ltd. |
Compositions and methods for t cell engineering
|
|
EP4146684A2
(en)
|
2020-05-08 |
2023-03-15 |
Alpine Immune Sciences, Inc. |
April and baff inhibitory immunomodulatory proteins with and without a t cell inhibitory protein and methods of use thereof
|
|
WO2022040577A1
(en)
*
|
2020-08-20 |
2022-02-24 |
City Of Hope |
Compositions and uses of cd45 targeted chimeric antigen receptor modified t cells
|
|
AU2021334950A1
(en)
*
|
2020-08-24 |
2023-03-02 |
Charité - Universitätsmedizin Berlin |
Chimeric antigen receptor (CAR)-expressing cells recognizing CEA
|
|
TW202216990A
(zh)
*
|
2020-09-08 |
2022-05-01 |
中國大陸商亘喜生物科技（上海）有限公司 |
用於ｔ細胞工程化的組合物和方法
|
|
WO2022061837A1
(en)
*
|
2020-09-27 |
2022-03-31 |
Jiangsu Cell Tech Medical Research Institute Co., Ltd. |
Fibronectin extra domain b (edb) -specific car-t for cancer
|
|
CN116783283A
(zh)
*
|
2020-11-13 |
2023-09-19 |
Gpb科学有限公司 |
产生具有增加的核酸摄取的细胞群体的方法
|
|
US11459372B2
(en)
|
2020-11-30 |
2022-10-04 |
Crispr Therapeutics Ag |
Gene-edited natural killer cells
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
CN116981685A
(zh)
*
|
2020-12-03 |
2023-10-31 |
世纪治疗股份有限公司 |
基因工程化细胞及其用途
|
|
KR20230118887A
(ko)
|
2020-12-03 |
2023-08-14 |
센츄리 쎄라퓨틱스 인코포레이티드 |
유전자 조작 세포 및 이의 용도
|
|
WO2022144632A1
(en)
|
2020-12-30 |
2022-07-07 |
Crispr Therapeutics Ag |
Compositions and methods for differentiating stem cells into nk cells
|
|
CN113234682B
(zh)
*
|
2021-01-12 |
2023-02-21 |
上海雅科生物科技有限公司 |
靶向cd7的工程化免疫细胞、嵌合抗原受体、cd7阻断分子及应用
|
|
CN112778427B
(zh)
*
|
2021-01-29 |
2022-03-15 |
武汉思安医疗技术有限公司 |
双特异性cs1-bcma car-t细胞及其应用
|
|
US20220267423A1
(en)
*
|
2021-02-22 |
2022-08-25 |
IgGenix, Inc. |
Ige antibodies cross-reactive to allergens and tumor antigens
|
|
CN112698037B
(zh)
*
|
2021-03-25 |
2021-06-25 |
北京积水潭医院 |
一种检测多发性骨髓瘤治疗效果的抗体组合物及其试剂盒和应用
|
|
WO2022234976A1
(ko)
*
|
2021-05-04 |
2022-11-10 |
주식회사 이뮤노로지컬디자이닝랩 |
키메릭 항원 수용체(car)를 포함하는 형질전환된 항원 특이적 전문적 항원표출세포 및 이의 용도
|
|
KR102671411B1
(ko)
*
|
2021-05-11 |
2024-06-04 |
진화섭 |
Baff 세포외 도메인을 포함하는 키메릭 항원 수용체 및 이의 용도
|
|
CN115340610A
(zh)
*
|
2021-05-12 |
2022-11-15 |
珠海市丽珠单抗生物技术有限公司 |
双特异性car t细胞及其应用
|
|
CN113402619B
(zh)
*
|
2021-06-30 |
2022-03-22 |
徐州医科大学 |
一种靶向B7H3共表达IL-21的全人源嵌合抗原受体、iNKT细胞及其用途
|
|
CN113549158B
(zh)
*
|
2021-07-19 |
2022-10-21 |
广州百暨基因科技有限公司 |
包含突变型il15以及嵌合抗原受体的融合蛋白
|
|
WO2023009989A1
(en)
*
|
2021-07-26 |
2023-02-02 |
Kite Pharma, Inc. |
Split chimeric antigen receptors and methods of use
|
|
WO2023028539A1
(en)
*
|
2021-08-24 |
2023-03-02 |
City Of Hope |
Nk cells expressing il-15 and checkpoint inhibitors for the treatment of cancer
|
|
KR20230032557A
(ko)
*
|
2021-08-31 |
2023-03-07 |
주식회사 이뮤노로지컬디자이닝랩 |
Baff 세포외 도메인을 포함하는 재조합 단백질 및 이를 유효성분으로 포함하는 암의 치료용 약학적 조성물
|
|
KR20240069748A
(ko)
*
|
2021-09-16 |
2024-05-20 |
지티 바이오파마, 인크. |
B7-h3 표적화 융합 단백질 및 그의 사용 방법
|
|
EP4433512A4
(en)
*
|
2021-11-19 |
2025-12-31 |
Univ Pennsylvania |
Genetically modified pan-leukocyte-specific CD45 antigen to facilitate T-lymphocyte therapy
|
|
US20230210900A1
(en)
*
|
2022-01-04 |
2023-07-06 |
Kyverna Therapeutics, Inc. |
Methods for treating autoimmune diseases
|
|
CN116606378A
(zh)
*
|
2022-02-08 |
2023-08-18 |
中国医学科学院血液病医院(中国医学科学院血液学研究所) |
靶向cd52的嵌合抗原受体及其应用
|
|
EP4272754A1
(en)
|
2022-05-04 |
2023-11-08 |
Universitätsklinikum Hamburg-Eppendorf |
Method for producing cells expressing a chimeric antigen receptor (car)
|
|
WO2023217796A1
(en)
*
|
2022-05-10 |
2023-11-16 |
Miltenyi Biotec B.V. & Co. KG |
Compositions comprising il-15, il-15 receptor alpha and the intracellular signaling domain of cd2 for immune cell therapy
|
|
WO2024026455A2
(en)
*
|
2022-07-29 |
2024-02-01 |
Shoreline Biosciences, Inc. |
Methods and compositions for generating chimeric antigen receptor-monocytes/macrophages
|
|
EP4487868A1
(en)
|
2023-07-06 |
2025-01-08 |
Universitätsklinikum Hamburg-Eppendorf |
Modified nk cell expressing a chimeric antigen receptor
|
|
WO2025059162A1
(en)
|
2023-09-11 |
2025-03-20 |
Dana-Farber Cancer Institute, Inc. |
Car-engager containing il-2 variants to enhance the functionality of car t cells
|
|
WO2025072372A1
(en)
*
|
2023-09-26 |
2025-04-03 |
The General Hospital Corporation |
Car-t cells expressing vegf binding proteins
|
|
CN117050195B
(zh)
*
|
2023-10-13 |
2023-12-19 |
旭和（天津）医药科技有限公司 |
一种靶向baffr嵌合抗原受体、car-t细胞和应用
|
|
WO2025264723A1
(en)
*
|
2024-06-18 |
2025-12-26 |
The University Of Chicago |
Co-expressed chimeric antigen receptors for cancer treatment
|
|
WO2026082736A1
(en)
*
|
2024-10-14 |
2026-04-23 |
Cimeio Therapeutics Ag |
Chimeric antigen receptor (car) that targets receptor-type tyrosine phosphatase c (cd45) and its use to related applications
|